SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Sandanger Torkjel)
 

Sökning: WFRF:(Sandanger Torkjel) > (2023) > Prediagnostic serum...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00010625naa a2200781 4500
001oai:DiVA.org:umu-206343
003SwePub
008230428s2023 | |||||||||||000 ||eng|
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-2063432 URI
0247 a https://doi.org/10.1002/ijc.344492 DOI
040 a (SwePub)umu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
1001 a Mao, Zilingu Department of Epidemiology, Rollins School of Public Health, Emory University, GA, Atlanta, United States; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, PA, Pittsburgh, United States4 aut
2451 0a Prediagnostic serum glyceraldehyde-derived advanced glycation end products and mortality among colorectal cancer patients
264 c 2023-03-20
264 1b John Wiley & Sons,c 2023
338 a print2 rdacarrier
520 a Glyceraldehyde-derived advanced glycation end products (glycer-AGEs) could contribute to colorectal cancer development and progression due to their pro-oxidative and pro-inflammatory properties. However, the association of glycer-AGEs with mortality after colorectal cancer diagnosis has not been previously investigated. Circulating glycer-AGEs were measured by competitive ELISA. Multivariable Cox proportional hazards models were used to calculate hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) for associations of circulating glycer-AGEs concentrations with CRC-specific and all-cause mortality among 1034 colorectal cancer (CRC) cases identified within the European Prospective Investigation into Cancer and Nutrition (EPIC) study between 1993 and 2013. During a mean of 48 months of follow-up, 529 participants died (409 from CRC). Glycer-AGEs were statistically significantly positively associated with CRC-specific (HRQ5 vs Q1 = 1.53, 95% CI: 1.04-2.25, Ptrend =.002) and all-cause (HRQ5 vs Q1 = 1.62, 95% CI: 1.16-2.26, Ptrend <.001) mortality among individuals with CRC. There was suggestion of a stronger association between glycer-AGEs and CRC-specific mortality among patients with distal colon cancer (per SD increment: HRproximal colon = 1.02, 95% CI: 0.74-1.42; HRdistal colon = 1.51, 95% CI: 1.20-1.91; Peffect modification =.02). The highest HR was observed among CRC cases in the highest body mass index (BMI) and glycer-AGEs category relative to lowest BMI and glycer-AGEs category for both CRC-specific (HR = 1.78, 95% CI: 1.02-3.01) and all-cause mortality (HR = 2.15, 95% CI: 1.33-3.47), although no statistically significant effect modification was observed. Our study found that prediagnostic circulating glycer-AGEs are positively associated with CRC-specific and all-cause mortality among individuals with CRC. Further investigations in other populations and stratifying by tumor location and BMI are warranted.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Arbetsmedicin och miljömedicin0 (SwePub)303032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Occupational Health and Environmental Health0 (SwePub)303032 hsv//eng
653 a advanced glycation end products
653 a colorectal cancer
653 a glyceraldehyde-derived advanced glycation end products
653 a mortality
653 a prospective study
7001 a Baker, Jacqueline Roshelliu Department of Epidemiology, Rollins School of Public Health, Emory University, GA, Atlanta, United States4 aut
7001 a Takeuchi, Masayoshiu Department of Advanced Medicine, Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan4 aut
7001 a Hyogo, Hideyukiu Department of Gastroenterology and Metabolism, Hiroshima University Hospital, Hiroshima, Japan; Lifecare Clinic Hiroshima, Hiroshima, Japan4 aut
7001 a Tjønneland, Anneu Danish Cancer Society Research Center, Diet, Cancer and Health, Copenhagen, Denmark; Department of Public Health, University of Copenhagen, Copenhagen, Denmark4 aut
7001 a Eriksen, Anne Kirstineu Danish Cancer Society Research Center, Diet, Cancer and Health, Copenhagen, Denmark4 aut
7001 a Severi, Gianlucau UVSQ, Inserm, Centre for Epidemiology and Population Health (U1018), Exposome and Heredity Team, Université Paris-Saclay, Villejuif, France; Department of Statistics, Computer Science Applications, “G. Parenti” University of Florence, Florence, Italy4 aut
7001 a Rothwell, Josephu UVSQ, Inserm, Centre for Epidemiology and Population Health (U1018), Exposome and Heredity Team, Université Paris-Saclay, Villejuif, France4 aut
7001 a Laouali, Nasseru UVSQ, Inserm, Centre for Epidemiology and Population Health (U1018), Exposome and Heredity Team, Université Paris-Saclay, Villejuif, France4 aut
7001 a Katzke, Verenau Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany4 aut
7001 a Kaaks, Rudolfu Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany4 aut
7001 a Schulze, Matthias B.u Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany4 aut
7001 a Palli, Domenicou Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network – ISPRO, Florence, Italy4 aut
7001 a Sieri, Sabinau Epidemiology and Prevention Unit, Fondazione IRCCS, Istituto Nazionale dei Tumori di Milano Via Venezian, Milan, Italy4 aut
7001 a de Magistris, Maria Santucciu Azienda Ospedaliera Universitaria Federico II, Naples, Italy4 aut
7001 a Tumino, Rosariou Hyblean Association for Epidemiological Research, AIRE ONLUS, Ragusa, Italy4 aut
7001 a Sacerdote, Carlottau Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital, Turin, Italy4 aut
7001 a Derksen, Jeroen W. G.u Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands4 aut
7001 a Gram, Inger T.u Department of Community Medicine, UiT-The Arctic University of Norway, Tromsø, Norway4 aut
7001 a Skeie, Guriu Department of Community Medicine, UiT-The Arctic University of Norway, Tromsø, Norway4 aut
7001 a Sandanger, Torkjel M.u Department of Community Medicine, UiT-The Arctic University of Norway, Tromsø, Norway4 aut
7001 a Quirós, Jose Ramónu Public Health Directorate, Asturias, Spain4 aut
7001 a Crous-Bou, Martau Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO) - Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Department of Epidemiology, Harvard T.H. Chan School of Public Health, MA, Boston, United States4 aut
7001 a Sánchez, Maria-Joseu Escuela Andaluza de Salud Pública (EASP), Granada, Spain; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Madrid, Spain; Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain4 aut
7001 a Amiano, Pilaru Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Madrid, Spain; Ministry of Health of the Basque Government, Sub Directorate for Public Health and Addictions of Gipuzkoa, San Sebastian, Spain; Epidemiology of Chronic and Communicable Diseases Group, Biodonostia Health Research Institute, San Sebastián, Spain4 aut
7001 a Colorado-Yohar, Sandra M.u Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Madrid, Spain; Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain; Research Group on Demography and Health, National Faculty of Public Health, University of Antioquia, Medellín, Colombia4 aut
7001 a Guevara, Marcelau Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Madrid, Spain; Navarra Public Health Institute, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain4 aut
7001 a Harlid, Sophia,d 1978-u Umeå universitet,Institutionen för strålningsvetenskaper4 aut0 (Swepub:umu)soha0105
7001 a Johansson, Ingegerdu Umeå universitet,Institutionen för odontologi4 aut0 (Swepub:umu)injo0003
7001 a Perez-Cornago, Aurorau Cancer Epidemiology Unit (CEU), Nuffield Department of Population Health, Medical Sciences Division, University of Oxford, Oxford, United Kingdom4 aut
7001 a Freisling, Heinzu Section of Nutrition and Metabolism, Nutritional Epidemiology Group, International Agency for Research on Cancer, World Health Organization (IARC-WHO), Lyon, France4 aut
7001 a Gunter, Marcu Section of Nutrition and Metabolism, Nutritional Epidemiology Group, International Agency for Research on Cancer, World Health Organization (IARC-WHO), Lyon, France4 aut
7001 a Weiderpass, Elisabeteu Office of the Director, International Agency for Research on Cancer (IARC-WHO), Lyon, France4 aut
7001 a Heath, Alicia K.u Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom4 aut
7001 a Aglago, Elomu Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom4 aut
7001 a Jenab, Mazdau Section of Nutrition and Metabolism, Nutritional Epidemiology Group, International Agency for Research on Cancer, World Health Organization (IARC-WHO), Lyon, France4 aut
7001 a Fedirko, Veronikau Department of Epidemiology, Rollins School of Public Health, Emory University, GA, Atlanta, United States; MD Anderson Cancer Center, TX, Houston, United States4 aut
7102 a Department of Epidemiology, Rollins School of Public Health, Emory University, GA, Atlanta, United States; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, PA, Pittsburgh, United Statesb Department of Epidemiology, Rollins School of Public Health, Emory University, GA, Atlanta, United States4 org
7730 t International Journal of Cancerd : John Wiley & Sonsg 152:11, s. 2257-2268q 152:11<2257-2268x 0020-7136x 1097-0215
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-206343
8564 8u https://doi.org/10.1002/ijc.34449

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy